A University of Minnesota spin-out, HennpinLife Sciences is developing treatments for women's health conditions with particular focus on anti-microbials to combat bacteria, fungus, virus and protozoa. The company is focused on addressing the pressing need for solutions to the increase in drug-resistant "super bugs." Hennepin is developing solutions for Bacterial vaginosis and candidiasis, Urinary Tract Infections, Skin and Soft Tissue Infections. It is possible that the firm's work has animal health and agricultural applications.
